Exact Sciences announces third quarter 2021 results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
Exact Sciences (EXAS) Misses Q3 EPS by 12c, Revenue Beats, Offers FY Guidance
November 2, 2021 4:26 PM EDTExact Sciences (NASDAQ: EXAS) reported Q3 EPS of ($0.97), $0.12 worse than the analyst estimate of ($0.85). Revenue for the quarter came in at $456.4 million versus the consensus estimate of $430.55 million.
GUIDANCE:
Exact Sciences sees 2021 revenue of $1.72-1.74 billion, versus the consensus of $1.73... More



